Zhiwen Zhang Selected Research

succinobucol (AGI 1067)

1/2021	Preferential Targeting Cerebral Ischemic Lesions with Cancer Cell-Inspired Nanovehicle for Ischemic Stroke Treatment.
2/2016	pH-Responsive Wormlike Micelles with Sequential Metastasis Targeting Inhibit Lung Metastasis of Breast Cancer.
1/2016	A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer.
5/2015	Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhiwen Zhang Research Topics

Disease

82	Neoplasms (Cancer) 10/2022 - 01/2009
34	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2011
32	Neoplasm Metastasis (Metastasis) 11/2021 - 02/2013
9	Scrub Typhus (Typhus, Scrub) 01/2022 - 06/2009
7	Glioma (Gliomas) 08/2021 - 04/2013
6	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2009
5	Carcinogenesis 01/2022 - 04/2004
5	Necrosis 01/2022 - 11/2010
5	Lung Neoplasms (Lung Cancer) 08/2014 - 01/2012
4	Adenocarcinoma 10/2022 - 01/2018
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2020
4	Carcinoma (Carcinomatosis) 01/2021 - 06/2012
3	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 09/2014
3	Meniere Disease (Menieres Disease) 01/2022 - 01/2020
3	Triple Negative Breast Neoplasms 03/2020 - 09/2015
3	Lymphatic Metastasis 01/2018 - 06/2014
3	Hypothermia 02/2015 - 08/2010
2	Endemic Flea-Borne Typhus (Typhus, Endemic Flea Borne) 01/2022 - 04/2008
2	Q Fever (Fever, Q) 01/2022 - 01/2014
2	Hypoxia (Hypoxemia) 12/2021 - 08/2015
2	Spinal Cord Injuries (Spinal Cord Injury) 12/2021 - 01/2021
2	Ischemic Stroke 10/2021 - 01/2021
2	Fever (Fevers) 08/2021 - 07/2012
2	Reperfusion Injury 01/2021 - 02/2015
2	Infections 12/2020 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 10/2020 - 05/2014
2	Hyperthermia 01/2016 - 06/2015

Drug/Important Bio-Agent (IBA)

31	Pharmaceutical PreparationsIBA 01/2022 - 01/2009
15	Small Interfering RNA (siRNA)IBA 01/2022 - 11/2012
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2004
10	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2017 - 10/2011
10	MicellesIBA 01/2017 - 10/2011
9	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2003
9	Paclitaxel (Taxol)FDA LinkGeneric 11/2016 - 01/2012
8	Peptides (Polypeptides)IBA 01/2021 - 06/2009
7	PolymersIBA 01/2017 - 03/2010
6	ProdrugsIBA 01/2021 - 01/2016
6	EnzymesIBA 11/2020 - 04/2008
6	AntigensIBA 05/2015 - 04/2008
5	Lipoproteins (Lipoprotein)IBA 04/2022 - 01/2019
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
5	Therapeutic UsesIBA 10/2021 - 11/2012
5	Immunoglobulin G (IgG)IBA 01/2021 - 06/2011
5	Sorafenib (BAY 43-9006)FDA Link 10/2020 - 05/2014
5	Biological ProductsIBA 01/2020 - 12/2011
5	Docetaxel (Taxotere)FDA Link 01/2016 - 01/2009
5	tocophersolanIBA 08/2014 - 11/2012
4	Long Noncoding RNAIBA 01/2022 - 01/2014
4	succinobucol (AGI 1067)IBA 01/2021 - 05/2015
4	asparaginylendopeptidase (legumain)IBA 10/2020 - 01/2017
4	VaccinesIBA 01/2020 - 06/2009
4	Liposomes (Liposome)IBA 01/2019 - 01/2012
4	Immunoglobulin M (IgM)IBA 10/2017 - 06/2011
4	AcidsIBA 01/2017 - 07/2013
4	GoldIBA 01/2016 - 09/2014
4	SurvivinIBA 10/2014 - 09/2012
3	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2013
3	Neuroprotective AgentsIBA 01/2021 - 03/2012
3	Oxygen (Dioxygen)IBA 01/2021 - 10/2020
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2017
3	Melitten (Melittin)IBA 01/2021 - 09/2020
3	Maytansine (Maitansine)IBA 01/2020 - 01/2016
3	LigandsIBA 01/2017 - 04/2010
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 02/2016 - 05/2015
3	NF-kappa B (NF-kB)IBA 01/2016 - 06/2014
3	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 09/2015
3	Poloxamer (Poloxamer 407)IBA 09/2015 - 11/2012
3	Nanoparticle Drug Delivery SystemIBA 09/2015 - 10/2011
3	Messenger RNA (mRNA)IBA 08/2015 - 04/2004
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 02/2015 - 08/2010
3	SolutionsIBA 08/2014 - 02/2013
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2014 - 04/2008
3	Lipid NanoparticlesIBA 09/2013 - 01/2009
2	Insulin (Novolin)FDA Link 10/2022 - 08/2011
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2022 - 09/2020
2	AntibodiesIBA 01/2022 - 01/2014
2	6-methyladenineIBA 01/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 12/2021 - 12/2020
2	cabazitaxel FDA Link 11/2021 - 01/2018
2	Formaldehyde (Formol)FDA Link 01/2021 - 01/2018
2	Gemcitabine FDA Link 01/2021 - 01/2021
2	ParaffinIBA 01/2021 - 01/2018
2	CollagenIBA 01/2021 - 11/2017
2	Phospholipids (Phosphatides)FDA LinkGeneric 11/2020 - 09/2020
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2020 - 02/2015
2	CurcuminIBA 01/2020 - 03/2015
2	ApoferritinsIBA 01/2020 - 12/2018
2	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 01/2017
2	Recombinant ProteinsIBA 10/2017 - 06/2011
2	5-hydroxymethylcytosineIBA 02/2016 - 02/2016

Therapy/Procedure

53	Therapeutics 10/2022 - 01/2010
23	Drug Therapy (Chemotherapy) 10/2020 - 09/2012
7	Lasers (Laser) 01/2021 - 09/2014
4	Immunotherapy 04/2022 - 01/2016
4	Intravenous Administration 11/2020 - 04/2010
3	Photochemotherapy (Photodynamic Therapy) 10/2020 - 01/2016
2	Intravenous Infusions 01/2021 - 12/2011
2	Precision Medicine 01/2021 - 01/2016
2	Intravenous Injections 03/2020 - 01/2018
2	Photothermal Therapy 03/2016 - 01/2016